Search Results

There are 28427 results for: content related to: Progression-free survival as a surrogate endpoint of overall survival in patients with metastatic renal cell carcinoma

  1. You have free access to this content
    Progression-free survival: Does a correlation with survival justify its role as a surrogate clinical endpoint?

    Cancer

    Volume 120, Issue 1, 1 January 2014, Pages: 7–10, Andreas Becker, Christian Eichelberg and Maxine Sun

    Version of Record online : 8 OCT 2013, DOI: 10.1002/cncr.28378

  2. You have free access to this content
    Bevacizumab and glioblastoma: Scientific review, newly reported updates, and ongoing controversies

    Cancer

    Volume 121, Issue 7, April 1, 2015, Pages: 997–1007, Kathryn M. Field, Justin T. Jordan, Patrick Y. Wen, Mark A. Rosenthal and David A. Reardon

    Version of Record online : 26 SEP 2014, DOI: 10.1002/cncr.28935

  3. You have full text access to this OnlineOpen article
    Annual Report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer

    Cancer

    Volume 120, Issue 9, 1 May 2014, Pages: 1290–1314, Brenda K. Edwards, Anne-Michelle Noone, Angela B. Mariotto, Edgar P. Simard, Francis P. Boscoe, S. Jane Henley, Ahmedin Jemal, Hyunsoon Cho, Robert N. Anderson, Betsy A. Kohler, Christie R. Eheman and Elizabeth M. Ward

    Version of Record online : 16 DEC 2013, DOI: 10.1002/cncr.28509

  4. You have free access to this content
    Skeletal muscle density predicts prognosis in patients with metastatic renal cell carcinoma treated with targeted therapies

    Cancer

    Volume 119, Issue 18, 15 September 2013, Pages: 3377–3384, Sami Antoun, Emilie Lanoy, Roberto Iacovelli, Laurence Albiges-Sauvin, Yohann Loriot, Mansouriah Merad-Taoufik, Karim Fizazi, Mario di Palma, Vickie E. Baracos and Bernard Escudier

    Version of Record online : 25 JUN 2013, DOI: 10.1002/cncr.28218

  5. You have free access to this content
    MYC-associated and double-hit lymphomas: A review of pathobiology, prognosis, and therapeutic approaches

    Cancer

    Volume 120, Issue 24, December 15, 2014, Pages: 3884–3895, Adam M. Petrich, Chadi Nabhan and Sonali M. Smith

    Version of Record online : 24 JUL 2014, DOI: 10.1002/cncr.28899

  6. You have free access to this content
    Stereotactic ablative radiotherapy: A potentially curable approach to early stage multiple primary lung cancer

    Cancer

    Volume 119, Issue 18, 15 September 2013, Pages: 3402–3410, Joe Y. Chang, Yung-Hsien Liu, Zhengfei Zhu, James W. Welsh, Daniel R. Gomez, Ritsuko Komaki, Jack A. Roth and Stephen G. Swisher

    Version of Record online : 24 JUN 2013, DOI: 10.1002/cncr.28217

  7. You have free access to this content
    Medical management of metastatic medullary thyroid cancer

    Cancer

    Volume 120, Issue 21, November 1, 2014, Pages: 3287–3301, Jessica E. Maxwell, Scott K. Sherman, Thomas M. O'Dorisio and James R. Howe

    Version of Record online : 18 JUN 2014, DOI: 10.1002/cncr.28858

  8. You have free access to this content
    Treatment of advanced thyroid cancer with axitinib: Phase 2 study with pharmacokinetic/pharmacodynamic and quality-of-life assessments

    Cancer

    Volume 120, Issue 17, September 1, 2014, Pages: 2694–2703, Laura D. Locati, Lisa Licitra, Laura Agate, Sai-Hong I. Ou, Andree Boucher, Barbara Jarzab, Shukui Qin, Madeleine A. Kane, Lori J. Wirth, Connie Chen, Sinil Kim, Antonella Ingrosso, Yazdi K. Pithavala, Paul Bycott and Ezra E. W. Cohen

    Version of Record online : 20 MAY 2014, DOI: 10.1002/cncr.28766

  9. You have free access to this content
    A phase 2, single-arm study of ramucirumab in patients with metastatic renal cell carcinoma with disease progression on or intolerance to tyrosine kinase inhibitor therapy

    Cancer

    Volume 120, Issue 11, 1 June 2014, Pages: 1647–1655, Jorge A. Garcia, Gary R. Hudes, Toni K. Choueiri, Walter M. Stadler, Laura S. Wood, Jayne Gurtler, Shailender Bhatia, Adarsh Joshi, Rebecca R. Hozak, Yihuan Xu, Jonathan D. Schwartz and John A. Thompson

    Version of Record online : 27 FEB 2014, DOI: 10.1002/cncr.28634

  10. You have free access to this content
    Gastroenteropancreatic high-grade neuroendocrine carcinoma

    Cancer

    Volume 120, Issue 18, September 15, 2014, Pages: 2814–2823, Halfdan Sorbye, Jonathan Strosberg, Eric Baudin, David S. Klimstra and James C. Yao

    Version of Record online : 25 APR 2014, DOI: 10.1002/cncr.28721

  11. You have free access to this content
    Intraobserver and interobserver variability in computed tomography size and attenuation measurements in patients with renal cell carcinoma receiving antiangiogenic therapy: Implications for alternative response criteria

    Cancer

    Volume 120, Issue 5, 1 March 2014, Pages: 711–721, Katherine M. Krajewski, Mizuki Nishino, Yoko Franchetti, Nikhil H. Ramaiya, Annick D. Van den Abbeele and Toni K. Choueiri

    Version of Record online : 21 NOV 2013, DOI: 10.1002/cncr.28493

  12. You have free access to this content
    Patient preferences in advanced or recurrent ovarian cancer

    Cancer

    Volume 120, Issue 23, December 1, 2014, Pages: 3651–3659, Laura J. Havrilesky, Angeles Alvarez Secord, Jessie A. Ehrisman, Andrew Berchuck, Fidel A. Valea, Paula S. Lee, Stephanie L. Gaillard, Greg P. Samsa, David Cella, Kevin P. Weinfurt, Amy P. Abernethy and Shelby D. Reed

    Version of Record online : 4 AUG 2014, DOI: 10.1002/cncr.28940

  13. You have free access to this content
    Therapeutic strategies for neuroendocrine liver metastases

    Cancer

    Volume 121, Issue 8, April 15, 2015, Pages: 1172–1186, Andrea Frilling and Ashley K. Clift

    Version of Record online : 1 OCT 2014, DOI: 10.1002/cncr.28760

  14. You have free access to this content
    A randomized phase 2 trial of erlotinib versus pemetrexed as second-line therapy in the treatment of patients with advanced EGFR wild-type and EGFR FISH-positive lung adenocarcinoma

    Cancer

    Volume 120, Issue 9, 1 May 2014, Pages: 1379–1386, Ning Li, Wei Ou, Hua Yang, Qian-Wen Liu, Song-Liang Zhang, Bao-Xiao Wang and Si-Yu Wang

    Version of Record online : 30 JAN 2014, DOI: 10.1002/cncr.28591

  15. You have free access to this content
    Population-based cancer registries for quality-of-life research

    Cancer

    Volume 119, Issue S11, 1 June 2013, Pages: 2109–2123, Melissa S. Y. Thong, Floortje Mols, Kevin D. Stein, Tenbroeck Smith, Jan-Willem W. Coebergh and Lonneke V. van de Poll-Franse

    Version of Record online : 20 MAY 2013, DOI: 10.1002/cncr.28056

  16. You have free access to this content
    Management of acquired resistance to epidermal growth factor receptor kinase inhibitors in patients with advanced non-small cell lung cancer

    Cancer

    Volume 120, Issue 15, August 1, 2014, Pages: 2289–2298, Adrian G. Sacher, Pasi A. Jänne and Geoffrey R. Oxnard

    Version of Record online : 17 APR 2014, DOI: 10.1002/cncr.28723

  17. You have free access to this content
    Complete response to induction therapy in patients with Myc-positive and double-hit non-Hodgkin lymphoma is associated with prolonged progression-free survival

    Cancer

    Volume 120, Issue 11, 1 June 2014, Pages: 1677–1685, Jonathon B. Cohen, Susan M. Geyer, Gerard Lozanski, Weiqiang Zhao, Nyla A. Heerema, Nathan C. Hall, Veena A. Nagar, Jessica A. Hemminger, Jeffrey A. Jones, Pierluigi Porcu, Beth A. Christian, Robert A. Baiocchi, Kami J. Maddocks, Joseph M. Flynn, Steven M. Devine and Kristie A. Blum

    Version of Record online : 27 FEB 2014, DOI: 10.1002/cncr.28642

  18. You have free access to this content
    A randomized phase 2 trial of gemcitabine/cisplatin with or without cetuximab in patients with advanced urothelial carcinoma

    Cancer

    Volume 120, Issue 17, September 1, 2014, Pages: 2684–2693, Maha Hussain, Stephanie Daignault, Neeraj Agarwal, Petros D. Grivas, Arlene O. Siefker-Radtke, Igor Puzanov, Gary R. MacVicar, Ellis Glenn Levine, Sandy Srinivas, Przemyslaw Twardowski, Mario A. Eisenberger, David I. Quinn, Ulka N. Vaishampayan, Evan Y. Yu, Scott Dawsey, Kathleen C. Day, Mark L. Day, Mahmoud Al-Hawary and David C. Smith

    Version of Record online : 6 MAY 2014, DOI: 10.1002/cncr.28767

  19. You have free access to this content
    A randomized, open-label clinical trial of tasisulam sodium versus paclitaxel as second-line treatment in patients with metastatic melanoma

    Cancer

    Volume 120, Issue 13, 1 July 2014, Pages: 2016–2024, Omid Hamid, Robert Ilaria Jr, Claus Garbe, Pascal Wolter, Michele Maio, Thomas E. Hutson, Ana Arance, Paul Lorigan, Jeeyun Lee, Axel Hauschild, Peter Mohr, Marjo Hahka-Kemppinen, Christopher Kaiser, P. Kellie Turner, Ilaria Conti and Jean-Jacques Grob

    Version of Record online : 26 MAR 2014, DOI: 10.1002/cncr.28635

  20. You have full text access to this OnlineOpen article
    A phase 2 trial of dacomitinib (PF-00299804), an oral, irreversible pan-HER (human epidermal growth factor receptor) inhibitor, in patients with advanced non–small cell lung cancer after failure of prior chemotherapy and erlotinib

    Cancer

    Volume 120, Issue 8, 15 April 2014, Pages: 1145–1154, Karen L. Reckamp, Giuseppe Giaccone, D. Ross Camidge, Shirish M. Gadgeel, Fadlo R. Khuri, Jeff A. Engelman, Marianna Koczywas, Arun Rajan, Alicyn K. Campbell, Diana Gernhardt, Ana Ruiz-Garcia, Stephen Letrent, Jane Liang, Ian Taylor, Joseph P. O'Connell and Pasi A. Jänne

    Version of Record online : 5 FEB 2014, DOI: 10.1002/cncr.28561